Compare GH & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GH | COKE |
|---|---|---|
| Founded | 2011 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 12.4B |
| IPO Year | 2018 | 1994 |
| Metric | GH | COKE |
|---|---|---|
| Price | $85.33 | $184.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 19 | 0 |
| Target Price | ★ $119.79 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 451.9K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.53% |
| EPS Growth | 6.74 | ★ 156.81 |
| EPS | N/A | ★ 1.21 |
| Revenue | $982,021,000.00 | ★ $7,228,055,000.00 |
| Revenue This Year | $33.30 | N/A |
| Revenue Next Year | $28.19 | N/A |
| P/E Ratio | ★ N/A | $154.89 |
| Revenue Growth | ★ 32.88 | 4.76 |
| 52 Week Low | $36.36 | $105.21 |
| 52 Week High | $120.74 | $1,421.32 |
| Indicator | GH | COKE |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 42.72 |
| Support Level | $82.33 | $177.28 |
| Resistance Level | $90.28 | $209.24 |
| Average True Range (ATR) | 5.42 | 7.78 |
| MACD | -0.01 | -1.56 |
| Stochastic Oscillator | 46.22 | 24.63 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Coca-Cola Consolidated Inc distributes, markets, and manufactures nonalcoholic beverages. It offers a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages, and the Company's principal sparkling beverage is Coca-Cola. Still beverages include energy products and non-carbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices, and sports drinks. The Company has two operating segments: Nonalcoholic Beverages and All Other. Key revenue is generated from Nonalcoholic Beverages.